Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Optimal post-remission therapy for adolescents and young adults (AYAs) with Ph-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is not established. We compared overall survival (OS), disease-free survival (DFS), relapse, and non-relapse mortality (NRM) for patients recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieduwilt, Matthew J., Stock, Wendy, Advani, Anjali, Luger, Selina, Larson, Richard A., Tallman, Martin, Appelbaum, Frederick, Zhang, Mei-Jie, Bo-Subait, Khalid, Wang, Hai-Lin, Bhatt, Vijaya Raj, Dholaria, Bhagirathbhai, Eapen, Mary, Hamadani, Mehdi, Jamy, Omer, Prestidge, Tim, Pulsipher, Michael, Ritchie, David, Rizzieri, David, Sharma, Akshay, Barba, Pere, Sandmaier, Brenda M., de Lima, Marcos, Kebriaei, Partow, Litzow, Mark, Saber, Wael, Weisdorf, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257494/
https://www.ncbi.nlm.nih.gov/pubmed/33785862
http://dx.doi.org/10.1038/s41375-021-01213-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257494/
https://www.ncbi.nlm.nih.gov/pubmed/33785862
http://dx.doi.org/10.1038/s41375-021-01213-5

Ejemplares similares